Echo IQ is trading 5% down at A$0.57, with no confirmed company-specific catalyst for October 1, 2026.
- The ASX announcement list shows no October 1 update; the latest listed company update is dated September 17.
- The recent FDA application update is prior news, not a confirmed explanation for the decline.
- Supplied broader-market figures do not show a significant same-direction move.